Earnings Summary

Jazz Pharmaceuticals Plc’s revenue jumped 4.1% since last year same period to $1011.94Mn in the Q4 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 4.09% jump in its revenue since last 3-months.

Jazz Pharmaceuticals Plc’s net profit jumped 139.24% since last year same period to $94.15Mn in the Q4 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated -35.87% fall in its net profits since last 3-months.

Jazz Pharmaceuticals Plc’s net profit margin jumped 137.7% since last year same period to 9.3% in the Q4 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated -38.39% fall in its net profit margins since last 3-months.

Jazz Pharmaceuticals Plc’s price-to-earnings ratio after this Q4 2023 earnings stands at 18.18.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 4.2 - a -18.92% fall from last quarter’s estimates.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 4.2.

Jazz Pharmaceuticals Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2024. This indicates that the Jazz Pharmaceuticals Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.